Aegerion Pharmaceuticals Inc $36.09

up +5.47


30/7/2014 02:20 PM  |  NASDAQ : AEGR  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get AEGR Trend Analysis - it has underperformed the S&P 500 by 77%

Partner Headlines

  1. Twitter Jumps On Upbeat Results; DreamWorks Shares Slide

    Benzinga
  2. Markets Mixed; Sprint Posts Profit

    Benzinga
  3. Benzinga's Volume Movers

    Benzinga
  4. Morning Market Movers

    Benzinga
  5. Benzinga's Top #PreMarket Gainers

    Benzinga
  6. Stocks Hitting 52-Week Lows

    Benzinga
  7. 5-Star Biotech Stock Watch: Aegerion Pharmaceuticals

    Benzinga
  8. Stocks Hitting 52-Week Lows

    Benzinga
  9. Weekly CEO Buys Highlight: GEO, TRUE, BANC, AEGR, CLMS

    GuruFocus
  10. Four CEOs Reporting Large Insider Buys

    GuruFocus
  11. Morning Market Losers

    Benzinga
  12. UPDATE: Aegerion Pharma Commences Phase 3 Clinical Trial in Japan, Will ...

    Benzinga
  13. Aegerion's JUXTAPID Capsules Approved in Mexico for Treatment of Homozygous ...

    Benzinga
  14. Leerink Swann Reiterates on Aegerion Pharmaceuticals as Weakness is Overdone

    Benzinga
  15. Canaccord Genuity Reiterates on Aegerion Pharmaceuticals as Selling is ...

    Benzinga
  16. Aegerion Pharmaceuticals Presents Data From Phase 3 Extension Study of ...

    Benzinga
  17. UPDATE: Deutsche Bank Reiterates on Aegerion Pharmaceuticals Following ...

    Benzinga
  18. Market Wrap For November 8: Markets Erase Thursday's Losses; Dow Companies ...

    Benzinga
  19. Benzinga's Top Pre-Market Gainers

    Benzinga
  20. $176,000 or $295,00 a Year: Bizarre World of Orphan Drugs

    YCharts
  21. Mid-Morning Market Update: Markets Heading Down, Dendreon Rockets Upwards

    Benzinga
  22. UPDATE: Canaccord Genuity Reiterates Buy Rating, Raises PT on Aegerion ...

    Benzinga
  23. Aegerion Pharmaceuticals Grants Stock Options to Purchase 55K Shares

    Benzinga
  24. My 3 Favorite Dividend Stocks at All-Time-Highs | Stock List

    GuruFocus
  25. UPDATE: Jefferies Raises PT to $29 on Aegerion Pharmaceuticals on Juxtapid ...

    Benzinga
  26. Canaccord Genuity Reiterates Buy Rating, $27 PT on Aegerion Pharmaceuticals

    Benzinga
  27. Stocks To Watch For December 26, 2012

    Benzinga
  28. Aegerion's Juxtapid OK'd

    IBD
  29. UPDATE: J.P. Morgan Reiterates Overweight Rating, Raises PT on Aegerion ...

    Benzinga
  30. FDA Approves Aegerion's' JUXTAPID Capsules for Homozygous Familial Hypercholesterolemia

    Benzinga
  31. Benzinga's M&A Chatter for Friday December 7, 2012

    Benzinga
  32. Aegerion Pharma Reserves Shares for Inducement Stock Options

    Benzinga
  33. Aegerion Pharmaceuticals Issued Patent by European Patent Office

    Benzinga
  34. BioMarin Stock Soars On Positive Drug Data

    IBD
  35. UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Aegerion ...

    Benzinga
  36. FDA EMDAC Recommends Approval of Lomitapide for Treatment of Homozygous ...

    Benzinga
  37. FDA Advisers Vote 13-2 that Aegerion Data Sufficient For Approval

    Benzinga
  38. Benzinga Mid-Afternoon Market Update

    Benzinga
  39. Benzinga Mid-Day Market Update

    Benzinga
  40. Benzinga Mid-Afternoon Market Update

    Benzinga
  41. Benzinga Mid-Morning Market Update

    Benzinga
  42. Options Alert - Aegerion Pharmaceuticals

    Benzinga
  43. UPDATE: J.P. Morgan Initiates Coverage on Aegerion Pharmaceuticals with ...

    Benzinga
  44. Aegerion Pharmaceuticals Announces Date of FDA Advisory Committee Review ...

    Benzinga
  45. Health Care Sector Wrap

    FoxBusiness
  46. Health Care Sector Wrap

    FoxBusiness
  47. Health Care Sector Wrap

    FoxBusiness
  48. Social Media Outlook for Friday June 15 (IGT, AEGR, AOL, GS)

    Benzinga
  49. Benzinga's Top Pre-Market Losers

    Benzinga
  50. Aegerion Pharmaceuticals Prices 3.4M Share Public Offering of Common Stock ...

    Benzinga
Trading Center